| Literature DB >> 35765305 |
Ray Portela1, Ahmet Vahibe1, Joseph N Badaoui1, Omer U I Hassan1, Travis J Mckenzie1, Todd A Kellogg1, Omar M Ghanem1.
Abstract
Background: Bariatric surgery is the most effective treatment for weight loss and obesity-related comorbidity resolution. However, bariatric surgery is not readily offered in specific populations due to the lack of data assessing its feasibility. This study intends to evaluate bariatric surgery in patients with an existing ostomy.Entities:
Keywords: bariatrics; gastrointestinal; minimally invasive surgery; obesity
Year: 2022 PMID: 35765305 PMCID: PMC9233518 DOI: 10.1089/bari.2021.0131
Source DB: PubMed Journal: Bariatr Surg Pract Patient Care ISSN: 2168-023X Impact factor: 0.368
Demographics and Clinical Baseline
| Factor | Overall |
|---|---|
|
| 6 |
| Age, mean (SD) | 58 (± 11.86) |
| BMI, mean (SD) | 41.59 (± 16.34) |
| Gender: female, | 4 (66.67) |
| Race, | |
| White | 5 (83.34) |
| Other | 1 (16.67) |
| Diabetes mellitus type II | 4 (66.67) |
| Hyperlipidemia | 4 (66.67) |
| Hypertensive requiring medication | 4 (66.67) |
| Current smoker within 1 year | 0 (0) |
| Obstructive sleep apnea | 3 (50.00) |
| Therapeutic anticoagulation | 2 (33.34) |
| Immunosuppression | 2 (33.34) |
| GERD requiring medication | 5 (83.34) |
| ASA class, | |
| 3 | 5 (83.34) |
| 4 | 1 (16.67) |
| Year of operation, | |
| 2018 | 3 (50.00) |
| 2020 | 1 (16.67) |
| 2021 | 2 (33.34) |
| Surgical procedure, | |
| Roux-en-Y gastric bypass | 2 (33.34) |
| Sleeve gastrectomy | 4 (66.67) |
ASA, American Society of Anesthesiologists; BMI, body mass index; GERD, gastroesophageal reflux disease; SD, standard deviation.
Ostomy
| Factor | Overall |
|---|---|
|
| 6 |
| Ileostomy, | 3 (50.00) |
| Colostomy, | 3 (50.00) |
| Years of ostomy before surgery, mean (SD) | 11.67 (±8.98) |
| Ended ostomy, | 6 (100) |
| Parastomal hernia, | 4 (66.67) |
| Cause of ostomy, | |
| Trauma | 2 (33.34) |
| IBD | 2 (33.34) |
| Cancer | 1 (16.67) |
| Scleroderma/fecal incontinence | 1 (16.67) |
IBD, inflammatory bowel disease.
Postoperative Follow-Up
| Factor | Overall |
|---|---|
|
| 4 |
| Mean follow-up (SD) | 23 months (16.43) |
| Mean percentage of weight loss (SD) | 15.50% (11.77) |
| Upto 30 days complications, | |
| Postoperative ED visit | 1 (25.00) |
| Conversion to open | 0 (00) |
| Visits to an infusion center | 0 (00) |
| Upto 3 years complications, | |
| Bariatric revision—SG to RYGB | 1 (25.00) |
| Dumping | 1 (25.00) |
| Anastomotic stricture | 1 (25.00) |
ED, emergency department; RYGB, Roux-en-Y gastric bypass; SG, sleeve gastrectomy.